February 2021 research newsletter

In this first newsletter of 2021, and my first as the new Director of Research, I wanted to start by acknowledging the sheer resilience and determination that you all have demonstrated by continuing your research endeavors at pace despite another – hopefully last – lockdown and whilst juggling the joys and tribulations of managing it alongside family and caring needs.

我还必须感谢这里与关节炎的出色员工和同事同样努力地确保我们以自己的方式为您和研究议程提供支持 - 无论是支持新的和激动人心beplay体育怎么下载的伙伴关系Juvenile Idiopathic Arthritis (JIA)，将参与JIA研究的世界上最大的儿童和年轻人汇集在一起​​，或者延长临床研究奖学金的截止日期，以确保我们能够获得最佳的研究和研究人员。

In January, when I took over the very strong and vibrant portfolio that Stephen Simpson and the team had built over the last eight years, we both spoke to you of our vision and aspirations for MSK research and how Versus Arthritis can play a pivotal part in achieving it – empowering both those who do research and those who benefit from it. Our forthcoming Research Strategy will hopefully speak to this and I would very much like to speak to as many of you as possible - to hear your views on where and how we can make a difference.

It is only by enabling diverse perspectives and views to come forward that we create something strong, rich and diverse – be it our next Research Strategy or ourselves as an organisation. Therefore, I am delighted that in my first newsletter I can highlight where we have taken steps to enable greater access, inclusion and openness via our work with AMRC on open access and also our own through reflection of how we continue to be organisation that is true to its commitment towards diversity and equality in its true sense.

愉快的阅读。

After eight fruitful years, Dr Stephen Simpson left Versus Arthritis at the end of January. In his time at the charity Stephen has worked with our talented research community towards many notable achievements, including championing pain research and patient involvement.

随着斯蒂芬的前进，我们很高兴地宣布，Neha Issar-Brown博士将加入我们担任新的研究总监。Neha从奋斗中加入了我们的斗争，在那里她担任研究，政策和创新总监，并启动了该慈善机构首次以患者为中心的研究策略的制定。在此之前，NEHA领导了乌克里医学研究委员会（MRC）的人口健康和系统医学投资组合，并监督了MSK投资组合。

Read more about Stephen’s time at the charity, and Neha's appointment.

On 27 January, Versus Arthritis hosted a webinar to wave goodbye to Dr Stephen Simpson, and welcome our new Director of Research Dr Neha Issar-Brown.

如果你错过了，you can catch up by watching the video on our website。这包括斯蒂芬的个人反思，内容涉及他的任期，以及Neha在她的背景上的介绍以及吸引她担任与关节炎的角色的原因。beplay体育怎么下载

您可能知道，在2020年7月，该慈善机构内出现了欺凌和种族主义的员工指控。我们迅速发起了内部调查，建议我们对慈善机构已知的种族主义和欺凌行为的所有公开案件进行独立和外部审查，并对所有人力资源政策，实践和案件管理进行审查。在采购过程之后，就业专家告诉简。调查现已完成，我们现在可以对您的发现和结论以及我们正在做的事情进行更新。

It is only by creating a truly diverse and inclusive organisation that we will deliver our vision for people with arthritis.

阅读有关发现的更多信息以及我们解决这些发现的计划。

The UK JIA Biologics Register

我们很高兴宣布与英国风湿病学会（BSR）建立新的合作伙伴关系，以资助英国JIA（少年特发性关节炎）生物学登记册。

beplay体育怎么下载与关节炎和BSR的相对于关节炎已经进行了独立研究（由风湿性疾病儿童（BCRD）研究由与关节炎进行资助的研究，以及在英国医院资助的Etanercept研究（BSPAR ETN），以查看该研究生物学和生物仿制药对JIA的安全性和有效性。

这种新的合作伙伴关系将把这两项研究作为英国JIA Biologics Regist，这将成为全球最大的儿童和年轻人群体，参与了有关JIA的研究。

Read more about this new partnership, including what has already been achieved, but also including a look to the future.

我们已经加入了医学研究慈善协会（AMRC）开放研究平台

AMRC Open Research是一个开放存取出版平台对res吗earchers and charity staff. Currently 37 charities are signed up. Powered by F1000 it has been designed to give researchers increased control over the publishing process and provides an accessible home for all research outputs, going beyond the journal article. Its points of difference over standard journal open access publishing are speed, low cost and open peer review.

Do please consider this platform when you come to publishing. Whilst we currently have funds to pay for open access publishing, we will not be able to sustain current levels of investment long term given the high cost levied by some publishers. OurOpen Access policyasks researchers to consider all options for publishing to allow us to maximise the impact of our research, funded by public donations. We plan to review our approach to open access this coming year and we will ask you to engage with this work.

Please note that for a limited time, research funded by Versus Arthritis can be published for free on the platform. You might want to use it initially for outputs other than your main article. The platform welcomes a wide range of material.

要了解更多或讨论您的出版想法，您可以联系您的研究奖团队，或访问AMRC开放研究网站。

临床研究奖学金截止日期扩展

The deadline for our Clinical Research Fellowship call has been extended, from 10 February 2021 to 3 March 2021.

A full list of current opportunities and deadlines can be found below.

We’d love to highlight your work and share a bit about you on our social media channels. We know that our supporters want to learn more about our amazing research, and the people behind it!

If you’d like to feature on our social media channels, please send our Social Media Team a picture of you and 200 words including:

• A bit about you – who you are, why you became a researcher, what motivates you.
• A bit about your research – what it is, how it affects people with arthritis.
• 您的社交媒体帐户名称（如果您想被标记）。

请包括您认为我们的支持者可能会发现有趣的任何东西。如果您有任何疑问，请随时与我们的社交媒体团队取得联系：socialmedia@versusarthis.org。*要注意：对于Twitter，可以缩短完整帖子*

你们中的许多人将在3月底为即将到来的参考2021提交准备您的意见书。我们喜欢展示研究如何对关节炎患者的生活产生影响，因此请与我们分享您的故事！

护士和盟友健康专业实习
截止日期：2021年2月24日

临床研究奖学金
Deadline: extended to 3 March 2021

AMS临床讲师的入门赠款（合伙企业）
截止日期：2021年3月8日

If you have any feedback regarding our newsletter, or have any questions please email研究人员处理@与企业炎。